The Preclinical Imaging Market was valued at USD 4.18 billion in 2023 and is anticipated to reach USD 6.31 billion by 2032, growing at a CAGR of 4.69% over the forecast period from 2024 to 2032. The increasing reliance on preclinical imaging technologies for drug discovery, the rising demand for non-invasive imaging techniques, and the expansion of research...